Skip to content

Analysis of efficacy of biochemical markers and the method of the detection of abnormal prion protein in CSF of prio disease patients

Analysis of efficacy of biochemical markers and the method of the detection of abnormal prion protein in CSF of prio disease patients - Analysis of efficacy of markers in CSFof prio disease patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000003301
Enrollment
40
Registered
2012-03-31
Start date
2010-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prion disease

Interventions

None listed

Sponsors

Nagasaki University Graduate School of Biomedical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: prion disease patients

Exclusion criteria

Exclusion criteria: non-prion disease patients

Design outcomes

Primary

MeasureTime frame
the diagnostic markers of prion disease

Secondary

MeasureTime frame
the sensitivity and the specificity

Countries

Japan

Contacts

Public ContactKatsuya Satoh

Nagasaki University Graduate School of Biomedical Sciences Department of Molecular Microbiology and Immunology

satoh-prion@nagasaki-u.ac.jp09049918364

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026